Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.

[1]  Joe Y. Chang,et al.  Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy. , 2016, International journal of radiation oncology, biology, physics.

[2]  Abby J. Isaacs,et al.  Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis , 2016, British Medical Journal.

[3]  D. Boffa,et al.  Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. , 2016, The Journal of thoracic and cardiovascular surgery.

[4]  Peter Balter,et al.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. , 2015, The Lancet. Oncology.

[5]  Joe Y. Chang,et al.  Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  G. Rocco,et al.  Lobar and sub-lobar lung resection in octogenarians with early stage non-small cell lung cancer: factors affecting surgical outcomes and long-term results , 2015, General Thoracic and Cardiovascular Surgery.

[7]  Joe Y. Chang,et al.  Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. , 2014, JAMA surgery.

[8]  Matthew Schipper,et al.  Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis. , 2014, International journal of radiation oncology, biology, physics.

[9]  Joe Y. Chang,et al.  Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  Joe Y. Chang,et al.  Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone". , 2014, International journal of radiation oncology, biology, physics.

[11]  Joe Y. Chang,et al.  Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer , 2013, Cancer.

[12]  E. Smit,et al.  Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  Jeffrey D Bradley,et al.  Patterns of Failure after Stereotactic Body Radiation Therapy or Lobar Resection for Clinical Stage I Non–Small-Cell Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  Peter Balter,et al.  Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer , 2012, Radiation oncology.

[15]  Joe Y. Chang,et al.  Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[16]  Suresh Senan,et al.  Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[17]  John Cho,et al.  Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. , 2012, International journal of radiation oncology, biology, physics.

[18]  S. Senan,et al.  Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  A. Bernard,et al.  Surgical management and outcomes of elderly patients with early stage non-small cell lung cancer: a nested case-control study. , 2011, Chest.

[20]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[21]  M. Higashiyama,et al.  Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer. , 2010, The Annals of thoracic surgery.

[22]  J. Bradley,et al.  Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. , 2010, The Journal of thoracic and cardiovascular surgery.

[23]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[24]  Hong Ye,et al.  Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Benjamin D Smith,et al.  Future of cancer incidence in the United States: burdens upon an aging, changing nation. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Luketich,et al.  Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly. , 2009, The Annals of thoracic surgery.

[27]  E. Smit,et al.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[28]  D. Mannino,et al.  Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.

[29]  O. Miettinen,et al.  Survival of Patients with Stage I Lung Cancer Detected on CT Screening , 2008 .

[30]  V. Rusch,et al.  Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. , 2006, The Annals of thoracic surgery.

[31]  D. Sugarbaker,et al.  Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. , 2005, Chest.

[32]  R. Yancik,et al.  Aging and cancer in America. Demographic and epidemiologic perspectives. , 2000, Hematology/oncology clinics of North America.

[33]  D. Sugarbaker,et al.  New surgical options for elderly lung cancer patients. , 1999, Chest.

[34]  L V Rubinstein,et al.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.

[35]  C van Weel,et al.  Comorbidity of chronic diseases in general practice. , 1993, Journal of clinical epidemiology.

[36]  E. Noordijk,et al.  Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  R. Ginsberg,et al.  Modern thirty-day operative mortality for surgical resections in lung cancer. , 1983, The Journal of thoracic and cardiovascular surgery.

[38]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[39]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden , 2002, Cancer.

[40]  Benjamin F. Miller,et al.  Encyclopedia and dictionary of medicine, nursing, and allied health , 1978 .